Meta-Analysis: Effects of Hormonal Contraceptive Use and History of Sexually Transmitted Disease on the Risk of Cervical Cancer


  • Siti Damayanti Master’s Program in Public Health, Universitas Sebelas Maret
  • Uki Retno Budihastuti Department of Obstetrics and Gynecology, Dr. Moewardi Hospital, Surakarta/ Faculty of Medicine, Universitas Sebelas Maret
  • Bhisma Murti Master's Program in Public Health, Universitas Sebelas Maret



Background: Cervical cancer is a sexually transmitted disease (STD) with the fourth largest number of new cases and deaths worldwide. This study aimed to analyze the effects of the use of hormonal contraception and a history of STD on the risk of cervical cancer in women.

Subjects and Method: The meta-analysis was carried out using the PRISMA flowchart and the PICO model. Population: women of reproductive age. Intervention: use of hormonal contraception and history of sexually transmitted infections Comparison: not using hormonal contraception and history of sexually transmitted infections Outcome: Cervical Cancer. The process of searching for articles is by searching through online journal databases which include Google Scholar, Elsevier and PubMed. With keywords “oral pill” OR “1 month injection” OR “3 month injection” OR “implant” OR “hormonal contraception” AND “cervical cancer” OR “syphilis” OR “chlamydia” OR “herpes” OR “gonorrhea” OR ”HIV” AND “Sexually transmitted infections” AND “Cross sectional” AND aOR. Articles were selected using the PRISMA flow and data analysis using the Review Manager 5.3 application.

Results: This meta-analysis consisted of 12 articles from Africa and Asia . The total sample was 8,240. The use of hormonal contraception (aOR = 2.34; 95% CI= 1.83 to 4.66; p<0.001) and had history of STD (aOR = 1.97; 95% CI = 1.49 to 2.61; p<0.001) increased the risk of cervical cancer.

Conclusion: The use of hormonal contraception and has history of std increase the risk of cervical cancer.

Keywords: hormonal contraception, history of sexually transmitted infections, cervical cancer.

Correspondence: Siti Damayanti. Master’s Program in Public Health, Universitas Sebelas Maret. Jl. Ir Sutami No.36, Kentingan, Jebres, Surakarta 57126, Central Java, Indonesia. Email: Sitidamayanti269@gmail.­com.


Abebaw E, Tesfa M, Gezimu W, Bekele F, Duguma A (2022). Female health-care providers’ knowledge, attitude, and practice towards cervical cancer screening and associated factors in public hospitals of northwest ethiopia. SAGE Open Med. 10.

Abera GB, Abebe SM, Werku AG (2020). Demand for cervical cancer screening in tigray region of ethiopia in 2018: a community-based cross-sectional study. Int J Woens Health. 12.795 804.

Alimena S, Dvis J, Fichorova RN, Feldman S (2022). The vaginal microbiome: A complex milieu affecting risk of human papillomavirus persistence and cervicalccer. Curr Probl cancer. 46 (4).

Amado G, Weldegebreal F, Birhanu S, Dessie Y (2022). Cervical cancer screening practices and its associated factors among females of reproductive age in durame town, southern ethiopia. PLoS ONE, 17(12).

Belayneh T, Mitiku H, Weldebreal F (2019). Precancerous cervical lesion and its associated factors among hiv-infected women on art in amhara regional state, ethiopia: a hospital-based cross-sectional study. Int. J. Health Sci. 13(3): 1–6.

Berhanu T, Mamo E, Tewolde T,Beshir M. (2019). Knowledge of cervical cancer and its screening practice among health extension workers in addis ababa, Ethiopia. Prim Health Care. 9(2): 1 5.

Desta A, Kolahi AA, Gudeta M, Dirirsa D, Kebede A (2022). Willingness to utilize cervical cancer screening among Ethiopian women aged 30–65 years. Front. Glob. Womens Health. 10(3):1 12.

Globocon (2020). Number of New Cancer Cases in Indonesia. oday/data/factsheets/populations/360-indonesia-fact-sheets.pdf.

Kashyap N, Krishnan N, Kaur S, Ghai S (2019). Risk factors of cervical cancer: a case-control study. Asia-Pacific J Oncol Nurs. 6(3): 308 314. doi: 10.4103/apjon.apjon_73_18.

Kasim J, Kalu A, Kamara B, Alema H (2020). Cervical cancer screening service utilization and associated factors among women in the shabadino district, Southern Ethiopia. J Cancer-Epidemiol. 2(2):1 20.

Kusmiyati Y, Prasistyami A, Wahyuningsih HP, Widyasih H, Adnani QES (2019). Duration of hormonal contraception and risk of cervical cancer. Kesmas. 14(1): 9 13. doi:10.21109/kesmas.v14i1.2713.

Mekuria M, Edosa K, Endashaw M, Bala E, Chaka E, Deriba B,Tesfa B (2021). Prevalence of cervical cancer and associated factors among women attended cervical cancer screening center at gaha ndi memorial hospital, ethiopia. Cancer Inform. 20. 769351211068431

Ningrum SS, Indarto D, Wijaya M (2016). Employment status, family income, contraceptive availability, and their effects on the use of long term contraceptives in Sukoharjo, Central Java. J Matern Child Health. 01(03):179187.

Safitri D, Rahardjo S, Murti B (2020). Effects of peer based intervention on prevention behavior of sexually transmitted infections and unwanted pregnancy in adolescents: a meta-analysis. J Matern Child Health. 06:693 704.

Sekumade A, Okunade K, Olorunfemi G, Daramola E, Adenekan M, Okunowo A, Anorlu R (2019). Association between serum folate level and invasive cervical cancer at a university teaching hospital in south-west nigeria. J Cancer Res Pract.6(4):179. 3/jcrp.jcrp_24_19

Shen M, Zou Z, Bao H, Fairley CK, Canfell K, (2023). Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in china.

Songsiriphan A, Salang L, Somboonporn W, Eamudomkarn N, Nhokaew W, Kuchais it C, Harnlakorn P (2020). Knowledge, attitudes, and practices regarding cervical cancer screening among hiv infected women at srinagarind hospital: a cross-sectional study. Asian Pac J Cance Prev.21(10): 2979 2986. 21.10.2979

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A (2021). Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin. 71(3): 209-249, doi: 10.3322/caac.21660.

WHO (2020). Cervix Uteri. /today/data/factsheets/cancers/23-Cervix-uteri-fact-sheet.pdf.

William W, Ware A, Basa AH, Obungoloch J (2019). A pap-smear analysis tool (pat) for detection of cervical cancer from pap-smear images. Bio Med Eng.18(1): 634-686. doi: 10.1186/s12938019063

Yang J, Sasamoto N, Babic A, Vitonis AF, Townsend MK, Titus L, Cramer DW, (2021). Intrauterine device use and risk of ovarian cancer: results from the new england case-control study and nurses’ health studies. Int J Cancer. 149(1):75-83. doi: 10.1002/ijc.33531.

Yurtçu E, Doğan RA, Karaaslan B Mutlu S (2022).Relationship between awareness s of cervical cancer and hpv infection and attitudes towards hpv vaccine among women aged 15-49 years: a cross-sectional study. Sao Paulo Med J. 140(3): 349–355. doi: 10.1590/15163180.2021.0145.2707202

Yosin EP, Mudigdo A,Budihastuti UR (2016). Effect of hormonal contraceptive on sexual life, body mass index, skin health, and uterine bleeding, in women of reproduction age in Jombang, East Java. J Matern Child Health, 01(03): 146 160.




How to Cite

Damayanti, S., Budihastuti, U. R., & Murti, B. (2023). Meta-Analysis: Effects of Hormonal Contraceptive Use and History of Sexually Transmitted Disease on the Risk of Cervical Cancer. Journal of Maternal and Child Health, 8(6), 711–722.